申请人:Janssen Pharmaceutica NV
公开号:US20220177458A1
公开(公告)日:2022-06-09
The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as HPK1 inhibitors, useful for treating diseases such as cancer.